718 related articles for article (PubMed ID: 18499708)
21. [The anti-mullerian hormone--physiology and application into clinical practice].
Robeva R; Mekhandzhiev Ts; Tomova A; Kumanov F
Akush Ginekol (Sofiia); 2006; 45(7):50-4. PubMed ID: 17489169
[TBL] [Abstract][Full Text] [Related]
22. Reproductive adaptations to a large-brained fetus open a vulnerability to anovulation similar to polycystic ovary syndrome.
Barnett DK; Abbott DH
Am J Hum Biol; 2003; 15(3):296-319. PubMed ID: 12704707
[TBL] [Abstract][Full Text] [Related]
23. Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome.
Dewailly D; Barbotin AL; Dumont A; Catteau-Jonard S; Robin G
Front Endocrinol (Lausanne); 2020; 11():641. PubMed ID: 33013710
[TBL] [Abstract][Full Text] [Related]
24. [The role of insulin-like growth-factor binding proteins in normal and polycystic ovaries].
Vasiljević M; Prorocić M; Dragojević S; Tasić L; Ganović R; Stanimirović B
Srp Arh Celok Lek; 1998; 126(11-12):488-94. PubMed ID: 9921024
[TBL] [Abstract][Full Text] [Related]
25. Polycystic ovary syndrome: etiology and pathogenesis.
Matalliotakis I; Kourtis A; Koukoura O; Panidis D
Arch Gynecol Obstet; 2006 Jul; 274(4):187-97. PubMed ID: 16685527
[TBL] [Abstract][Full Text] [Related]
26. Developmental expression and cellular distribution of Mullerian inhibiting substance in the primate ovary.
Modi D; Bhartiya D; Puri C
Reproduction; 2006 Sep; 132(3):443-53. PubMed ID: 16940285
[TBL] [Abstract][Full Text] [Related]
27. Autophagy in ovary and polycystic ovary syndrome: role, dispute and future perspective.
Kumariya S; Ubba V; Jha RK; Gayen JR
Autophagy; 2021 Oct; 17(10):2706-2733. PubMed ID: 34161185
[TBL] [Abstract][Full Text] [Related]
28. New approach to polycystic ovary syndrome and other forms of anovulatory infertility.
Laven JS; Imani B; Eijkemans MJ; Fauser BC
Obstet Gynecol Surv; 2002 Nov; 57(11):755-67. PubMed ID: 12447098
[TBL] [Abstract][Full Text] [Related]
29. Anti-Müllerian hormone and folliculogenesis.
Visser JA; Themmen AP
Mol Cell Endocrinol; 2005 Apr; 234(1-2):81-6. PubMed ID: 15836956
[TBL] [Abstract][Full Text] [Related]
30. The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology.
Balen A
Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):685-706. PubMed ID: 15380141
[TBL] [Abstract][Full Text] [Related]
31. Stockpiling of transitional and classic primary follicles in ovaries of women with polycystic ovary syndrome.
Maciel GA; Baracat EC; Benda JA; Markham SM; Hensinger K; Chang RJ; Erickson GF
J Clin Endocrinol Metab; 2004 Nov; 89(11):5321-7. PubMed ID: 15531477
[TBL] [Abstract][Full Text] [Related]
32. Polycystic ovary syndrome: anomalies in progesterone production.
Doldi N; Gessi A; Destefani A; Calzi F; Ferrari A
Hum Reprod; 1998 Feb; 13(2):290-3. PubMed ID: 9557824
[TBL] [Abstract][Full Text] [Related]
33. Lysyl oxidase blockade ameliorates anovulation in polycystic ovary syndrome.
Zhang C; Ma J; Wang W; Sun Y; Sun K
Hum Reprod; 2018 Nov; 33(11):2096-2106. PubMed ID: 30272163
[TBL] [Abstract][Full Text] [Related]
34. Etiology of anovulation in polycystic ovary syndrome.
Franks S; Mason H; White D; Willis D
Steroids; 1998; 63(5-6):306-7. PubMed ID: 9618791
[TBL] [Abstract][Full Text] [Related]
35. Early origins of polycystic ovary syndrome.
Dumesic DA; Schramm RD; Abbott DH
Reprod Fertil Dev; 2005; 17(3):349-60. PubMed ID: 15745643
[TBL] [Abstract][Full Text] [Related]
36. A Hyperandrogenic Environment Causes Intrinsic Defects That Are Detrimental to Follicular Dynamics in a PCOS Mouse Model.
Bertoldo MJ; Caldwell ASL; Riepsamen AH; Lin D; Gonzalez MB; Robker RL; Ledger WL; Gilchrist RB; Handelsman DJ; Walters KA
Endocrinology; 2019 Mar; 160(3):699-715. PubMed ID: 30657917
[TBL] [Abstract][Full Text] [Related]
37. Biomechanical forces and signals operating in the ovary during folliculogenesis and their dysregulation: implications for fertility.
Fiorentino G; Cimadomo D; Innocenti F; Soscia D; Vaiarelli A; Ubaldi FM; Gennarelli G; Garagna S; Rienzi L; Zuccotti M
Hum Reprod Update; 2023 Jan; 29(1):1-23. PubMed ID: 35856663
[TBL] [Abstract][Full Text] [Related]
38. Erbb4 regulates the oocyte microenvironment during folliculogenesis.
Veikkolainen V; Ali N; Doroszko M; Kiviniemi A; Miinalainen I; Ohlsson C; Poutanen M; Rahman N; Elenius K; Vainio SJ; Naillat F
Hum Mol Genet; 2020 Oct; 29(17):2813-2830. PubMed ID: 32716031
[TBL] [Abstract][Full Text] [Related]
39. Hyperandrogenemia: pathophysiology and its role in ovulatory dysfunction in PCOS.
Diamanti-Kandarakis E; Papailiou J; Palimeri S
Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():198-204. PubMed ID: 16641860
[TBL] [Abstract][Full Text] [Related]
40. The insulin-like growth factor system in normal and abnormal human ovarian follicle development.
Giudice LC
Am J Med; 1995 Jan; 98(1A):48S-54S. PubMed ID: 7825641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
